QIAGEN N.V. Reports Second Quarter 2013 Results and Announces New Share Repurchase Program
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
VENLO, The Netherlands, July 30, 2013 /PRNewswire/ --
•Q2 2013 results: Adjusted net sales of $316.4 million (+3% CER) on growth in all regions; adjusted operating income of $83.4 million; adjusted diluted EPS of $0.27 per share
•Making progress to accelerate innovation and growth amid challenging conditions
Hey, check out all the research scientist jobs. Post your resume today!
VENLO, The Netherlands, July 30, 2013 /PRNewswire/ --
•Q2 2013 results: Adjusted net sales of $316.4 million (+3% CER) on growth in all regions; adjusted operating income of $83.4 million; adjusted diluted EPS of $0.27 per share
•Making progress to accelerate innovation and growth amid challenging conditions
Hey, check out all the research scientist jobs. Post your resume today!